Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes

NCT01234727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2026-03-23

No results posted yet for this study

Summary

A Multicentre study comparing 5 different Self-Monitoring Of Blood Glucose (SMBG) system commercially available in Germany \& Holland.

Conditions

Sponsors & Collaborators

  • ikfe-CRO GmbH

    collaborator INDUSTRY
  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Joe Bugler · Abbott Diabetes Care

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01234727 on ClinicalTrials.gov